Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantation
Ofrat Beyar‐Katz(Rambam Health Care Campus), Tsila Zuckerman(Johannes Gutenberg University Mainz), Yishai Ofran(Shaare Zedek Medical Center), Riva Fineman(Rambam Health Care Campus), Jacob M. Rowe(Technion – Israel Institute of Technology), Dana Yehudai‐Ofir(Rambam Health Care Campus), Nivin Moustafa-Hawash(Rambam Health Care Campus), Israel Henig(Rush University Medical Center), Shimrit Ringelstein‐Harlev(Rambam Health Care Campus), Nuhad Haddad(Rambam Health Care Campus), Noa Lavi(Rambam Health Care Campus), Dvora Sahar(Rambam Health Care Campus), Yuval Nov(University of Haifa)
Cited by 13
Related Papers
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859